UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | K | L | M | N | P | R | S | W | Z
Number of items: 75.

A

Adams, VC; Hunt, JR; Rosa Brunet, L; Rook, GAW; (2002) Effect of Mycobacterium vaccae on ICOS expression in a murine model. In: Immunology. (pp. 111 - 111).

Ahmed, SM; Al, H; Reid, WM; Johnson, MA; Poulter, LW; (2002) The cellular response associated with cervical intraepithelial neoplasia in HIV+ and HIV- subjects. Scandinavian Journal of Immunology , 56 (2) 204 - 211.

Ahn, JW; Powell, KL; Kellam, P; Alba, MM; (2002) Gammaherpesvirus lytic gene expression as characterised by DNA array. Journal of Virology , 76 (12) 6244 - 6256.

Arriaga, AK; Orozco, EH; Aguilar, LD; Rook, GAW; Pando, RH; (2002) Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. CLIN EXP IMMUNOL , 128 (2) 229 - 237.

B

Barry, SM; Condez, A; Johnson, MA; Janossy, G; (2002) Determination of bronchoalveolar lavage leukocyte populations by flow cytometry in patients investigated for respiratory disease-. CYTOMETRY , 50 (6) 291 - 297.

Barry, SM; Lipman, MC; Deery, A; Johnson, MA; Janossy, G; (2002) Immune reconstruction pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Medicine , 3 (3) 207 - 211.

Besnier, C.; Takeuchi, Y.; Towers, G.; (2002) Restriction of lentivirus in monkeys. Proceedings of the National Academy of Sciences , 99 (18) pp. 11920-11925. 10.1073/pnas.172384599.

Breivik, T; Rook, GAW; (2002) Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. J PERIODONTAL RES , 37 (3) 210 - 214.

Brett, PJ; Tiwana, H; Feavers, IM; Charalambous, BM; (2002) Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses. J BIOL CHEM , 277 (23) 20468 - 20476. 10.1074/jbc.M200387200. Gold open access

Brunet, LR; Hunt, J; Rook, GAW; (2002) Dangers of therapeutic manipulation of the Th1-Th2 balance. TRENDS IMMUNOL , 23 (3) 127 - 128.

C

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: twelve month use of linezolid for Gram-positive infections in ICU. In: (Proceedings) European Congress of Chemotherapy. : Paris.

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: use of linezolid for Gram-positive infections in ICU. In: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Hayman, SJ; Jones, K; ... Wilson, APR; + view all (2002) Linezolid versus teicoplanin in the treatment of Gram positive infections in the critically ill: a randomized, double-blind, multicentre study. In: (Proceedings) 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). : San Diego.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; ... Singer, M; + view all (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. In: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; ... Singer, M; + view all (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. In: (Proceedings) European Congress of Chemotherapy. : Paris.

Cepeda, JA; Whitehouse, T; Wilson, APR; Singer, M; Bellingan, G; Kibbler, C; Shaw, S; (2002) MRSA clearance during treatment with linezolid. In: (Proceedings) European Congress of Chemotherapy.

Charalambous, BM; (2002) Meningitis B vaccine. PCT/GB.

D

Deayton, JR; Sabin, CA; Britt, WB; Jones, IM; Wilson, P; Johnson, MA; ... Emery, VC; + view all (2002) Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS , 16 (16) 2129 - 2135.

Druilhe, P; Hagan, P; Rook, GAW; (2002) The importance of models of infection in the study of disease resistance. TRENDS MICROBIOL , 10 (10) S38 - S46.

E

Elsaghier, AAF; Aucken, HM; Hamilton-Miller, JM; Shaw, S; Kibbler, CC; (2002) Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection. J ANTIMICROB CHEMOTH , 49 (2) 423 - 424.

Emery, VC; Hassan-Walker, AF; (2002) Focus on new drugs in development against human cytomegalovirus. DRUGS , 62 (13) 1853 - 1858.

Emery, VC; Hassan-Walker, AF; Burroughs, AK; Griffiths, PD; (2002) Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J INFECT DIS , 185 (12) 1723 - 1728. Green open access
file

G

Gillespie, SH; (2002) Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and molecular perspective. ANTIMICROB AGENTS CH , 46 (2) 267 - 274.

Gillespie, SH; (2002) Microbes sans frontieres. LANCET , 359 (9301) 93 - 95.

Gillespie, SH; (2002) Organisms of surgical importance. Surgery , 20 186 - 189.

Gillespie, SH; (2002) Treatment of skin infections. PRESCRIBER

Gillespie, SH; (2002) Migrating worms. In: Armstrong Cohen, J, (ed.) Infectious Diseases. Elsevier Science Press

Gillespie, SH; (2002) New quinolones for respiratory infections: mechanisms of action and resistance. (Royal Society of Medicine, Round Table Series 76 ). Royal Society of Medicine: London.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug resistant tuberculosis: evidence for changing fitness on passage through human hosts. Microbial Drug Resistance , 8 1 - 7.

Gillespie, SH; Gosling, R; Charalambous, BM; (2002) A re-iterative method for calculating the early bactericidan activity of anti-tuberculosis drugs. American Journal of Respiratory and Critical Care Medicine , 166 (1) 31 - 35.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating bactericidal activity of antituberculosis drugs. American Journal of Respiratory and Critical Care Medicine , 166 (1) 31 - 35.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. AM J RESP CRIT CARE , 166 (1) 31 - 35. 10.1164/rccm.2112077.

Gillespie, SH; Tillotson, GS; (2002) Novel perspectives in antibacterial action. (Royal Society of Medicine, Round Table Series 76 ). Royal Society of Medicine

Gillespie, SH; Voelker, LL; Dickens, A; (2002) Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae. MICROB DRUG RESIST , 8 (2) 79 - 84.

H

Hails, J; Kwaku, F; Wilson, APR; Bellingan, G; Singer, M; (2002) Large variation in MRSA policies, procedures, and prevalence in English intensive care units. A questionnaire analysis. BRIT J ANAESTH , 89 (2) 354P - 355P.

Hassan-Walker, AF; Emery, VC; Griffiths, PD; (2002) Molecular diagnosis of cytomegalovirus disease. In: Trull, A and Demers, LM and Holt, DW and Johnston, A and Tredger, JM and Price, CP, (eds.) BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH. (pp. 467 - 473). CAMBRIDGE UNIV PRESS

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

Holzerlandt, R; Orengo, C; Kellam, P; Albà, MM; (2002) Identification of new herpesvirus gene homologs in the human genome. Genome Res , 12 (11) 1739 - 1748. 10.1101/gr.334302.

Huggett, JF; Mustafa, A; O'Neil, L; Mason, DJ; (2002) Does osteogenesis differentially regulate GLAST-1 and GLAST-1a? In: Bone. (pp. 6S - 6S).

K

Kellam, P; AlbÃ, MM; (2002) Virus bioinformatics: databases and recent applications. Applied Bioinformatics , 1 (1) 37 - 42.

Kellam, P; Mar Alba, M; (2002) Databases and recent applications. Applied Bioinformatics , 1 (1) 37 - 42.

Kellam, P; Xiaohui, L; Martin, NJ; Orengo, CA; Swift, S; Tucker, A; (2002) A framework for modelling virus gene expression data. Intelligent Data Analysis , 5 1 - 13.

Kunori, T; Cookson, B; Roberts, JA; Stone, S; Kibbler, C; (2002) Cost-effectiveness of different MRSA screening methods. J Hosp Infect , 51 (3) 189 - 200.

L

Leśnikowski, ZJ; Paradowska, E; Przepiórkiewicz, M; Olejniczak, A; Emery, VC; (2002) [Drugs against human cytomegalovirus]. Pol Merkur Lekarski , 13 (75) 242 - 249.

Lock, MJ; Thorley, N; Teo, J; Emery, VC; (2002) Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J ANTIMICROB CHEMOTH , 49 (2) 359 - 366.

M

Maguire, H; Dale, JW; McHugh, TD; Butcher, PD; Gillespie, SH; Costetsos, A; ... Banerjee, DK; + view all (2002) Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. THORAX , 57 (7) 617 - 622.

Mason, DJ; Huggett, JF; (2002) Glutamate transporters in bone. Journal of Musculoskeletal and Neuronal Interactions , 2 (5) 406 - 414.

Mays, S; Fysh, E; Taylor, GM; (2002) Periostitic rib lesions – a sign of pulmonary tuberculosis? American Journal of Physical Anthropology , 119 (1) 27 - 36.

Mays, S; Taylor, GM; (2002) Osteological and biomolecular study of two possible cases of hypertrophic osteoarthropathy from Mediaeval England. Journal of Archaeological Science , 29 1267 - 1276.

Mele, A; Paterson, PJ; Prentice, HG; Leoni, P; Kibbler, CC; (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. BONE MARROW TRANSPL , 29 (8) 691 - 698. 10.1038/sj/bmt/1703425.

Mele, A; Paterson, PJ; Prentice, HG; Leoni, P; Kibbler, CC; (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant , 29 (8) 691 - 698. 10.1038/sj.bmt.1703425.

Mistry, NF; Iyer, AM; D souza, DTB; Taylor, GM; Young, DB; Antia, NH; (2002) Mycobacterium tuberculosis Isolates from Multiple-Drug-Resistant Tuberculosis Patients from Bombay, India. Journal of Clinical Microbiology , 40 2677 - 2680.

N

Nokta, MA; Holland, F; De Gruttola, V; Emery, VC; Jacobson, MA; Griffiths, P; ... Int CMV Prophylaxis Study Grp,; + view all (2002) Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: Relationship to CMV disease. J INFECT DIS , 185 (12) 1717 - 1722.

P

Phillips, AN; Staszewski, S; Lampe, F; Youle, MS; Klauke, S; Bickel, M; ... Royal Free Ctr HIV Med Goethe Univ,; + view all (2002) Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. JOURNAL OF INFECTIOUS DISEASES , 186 (8) 1086 - 1091. Green open access
file

Pillay, D; Emery, VC; Mutimer, D; Ogilvie, MM; Carman, W; Mutton, K; ... Public Hlth Laboratory Service Adv,; + view all (2002) Guidelines for laboratory monitoring of treatment of persistent virus infections. J CLIN VIROL , 25 (1) 73 - 92.

R

Rook, GA; Brunet, LR; (2002) Give us this day our daily germs. Biologist (London) , 49 (4) 145 - 149.

Rook, GA; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends in Immunology , 23 (1) 18 - 22.

Rook, GAW; (2002) Immunoregulation: the hygiene hypothesis and the brain. In: Immunology. (pp. 40 - 40).

Rook, GAW; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. TRENDS IMMUNOL , 23 (1) 18 - 22.

Rook, GAW; Rosa Brunet, L; Hunt, J; (2002) Multiple consequences of the changing educational input to our immune systems. In: Heidt, PJ and Midtvedt, T and Rusch, V and van der Waaij, D, (eds.) Probiotics: Bacteria and Bacterial Fragments as Immunomodulatory Agents. (35 - 53). Institut f+r Integrative Biologie GmbH: Herborn-Dill, Germany.

Ruddy, M; Kibbler, CC; (2002) Endoscopic decontamination: an audit and practical review. J HOSP INFECT , 50 (4) 261 - 268. 10.1053/jhin.2002.1177.

Ruddy, M; McHugh, TD; Dale, JW; Banerjee, D; Maguire, H; Wilson, P; ... Gillespie, SH; + view all (2002) Estimation of the rate of unrecognized cross-contamination with Mycobacterium tuberculosis in London microbiology laboratories. J CLIN MICROBIOL , 40 (11) 4100 - 4104. 10.1128/JCM.40.11.4100-4104.2002.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; ... Lee, CA; + view all (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

Shepherd, AJ; Martin, NJ; Johnson, RG; Kellam, P; Orengo, CA; (2002) PFDB: a generic protein family database integrating the CATH domain structure database with sequence based protein family resources. BIOINFORMATICS , 18 (12) 1666 - 1672.

Stansby, G; Chan, YC; Berwanger, CS; Shurey, S; Rook, GAW; Stanford, JL; (2002) Prevention of experimental myointimal hyperplasia by immunomodulation. EUR J VASC ENDOVASC , 23 (1) 23 - 28. 10.1053/ejvs.2001.1549.

W

Wallace, SM; Walton, BI; Kharbanda, RK; Hardy, R; Wilson, AP; Swanton, RH; (2002) Mortality from infective endocarditis: clinical predictors of outcome. HEART , 88 (1) 53 - 60.

Whalley, S; Brown, D; Webster, G; Jacobs, R; Teo, CG; Emery, V; Dusheiko, G; (2002) Evolution of hepatitis B virus during primary infection: Relevance to virulence and outcome. J HEPATOL , 36 95 - 95.

Whalley, SA; Brown, D; Webster, GJM; Jacobs, R; Teo, CG; Emery, VC; Dusheiko, GM; (2002) Evolution of hepatitis B virus during primary infection. GUT , 50 A118 - A118.

Whalley, SA; Webster, GJM; Brown, D; Teo, CG; Bertoletti, A; Emery, VC; Dusheiko, GM; (2002) Transient generation of core CD8+ cytotoxic T-cell escape mutants during primary HBV infection. GUT , 50 A112 - A112.

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; ... Singer, M; + view all (2002) Treatment of bacteraemia and LRTI with linezolid in the critically ill patient: a randomized double-blind comparison against teicoplanin. In: (Proceedings) 15th Annual Congress of the European Society of Intensive Care Medicine.. : Barcelona.

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; ... Singer, M; + view all (2002) Bacteraemia & LRTI treatment with linezolid in the critically ill: a randomized double-blind. In: INTENSIVE CARE MEDICINE. (pp. S70 - S70). SPRINGER-VERLAG

Whiting, GC; Evans, JT; Patel, S; Gillespie, SH; (2002) Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic. J MED MICROBIOL , 51 (10) 837 - 843.

Z

Zuany-Amorim, C; Manlius, C; Trifilieff, A; Brunet, LR; Rook, G; Bowen, G; ... Walker, C; + view all (2002) Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J IMMUNOL , 169 (3) 1492 - 1499.

Zuany-Amorim, C; Sawicka, E; Manlius, C; Le Moine, AL; Brunet, LR; Kemeny, DM; ... Walker, C; + view all (2002) Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. NAT MED , 8 (6) 625 - 629. 10.1038/nm0602-625.

This list was generated on Sun Nov 23 13:40:27 2014 GMT.